Phone-Based Step Counting Program for Adults Living with Long-Term Stroke Effects
Tests a remote step count program with a therapist in stroke survivors.
Plain-language title generated from the registry record
Registry title: Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke
Key facts
- Where
- Minneapolis, United StatesSee the site
Where in United States
- University of MinnesotaMinneapolis, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Minnesota
- Trial code
- NCT07649135
- Record updated
- 10 July 2026
- Original description
The goal of this study is to explore the feasibility of a new approach to rehabilitation that focuses on step count. Participants will complete 6 telephone or Zoom-based sessions with an occupational therapist over 6 weeks and use a step count tracker during that time. They will also complete questionnaires, assessments, surveys, and physical activity measurements during study weeks 0 (baseline), 3 (mid-point), 7 (post-intervention) and 12 (follow-up).Read full original descriptionShow less
Feasibility of Engaging Stroke Survivors in a Brief Step Count Intervention During Chronic Stroke
The goal of this study is to explore the feasibility of a new approach to rehabilitation that focuses on step count. Participants will complete 6 telephone or Zoom-based sessions with an occupational therapist over 6 weeks and use a step count tracker during that time. They will also complete questionnaires, assessments, surveys, and physical activity measurements during study weeks 0 (baseline), 3 (mid-point), 7 (post-intervention) and 12 (follow-up).
Inclusion: Stroke diagnosis confirmed by imaging; Stroke occurred 6 or more months before study enrollment; Meet criteria for "inactive" on the International Physical Activity Questionnaire-Short Form; Able to identify a support person that they interact with in-person at least once per week; Able and willing to participate fully in the study and provide informed consent or proxy consent with participant assent.
Exclusion: Currently receiving care in a transitional care unit, skilled nursing facility, or other institutional care setting; Currently receiving outpatient neurorehabilitation services (e.g., physical therapy, occupational therapy, speech therapy); Received inpatient treatment or was hospitalized for a psychiatric condition and/or alcohol or substance abuse within the past 12 months; Current diagnosis of a terminal illness and/or currently receiving hospice care; Concurrent participation in another rehabilitation intervention research study; Currently pregnant or expecting to become pregnant in the next 8 weeks Comorbid neurological disorder (Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma, spinal cord injury, cerebral palsy); Comorbid cancer, currently undergoing chemotherapy or radiation treatment; History of allergic reaction to adhesives that precludes the use of an adhesive necessary for adherence to activPAL measurement; Severe cognitive or communication impairments (inability to respond accurately to complete study screening questions or to provide informed consent or assent); Uses wheelchair as primary mobility aid outside of home setting; Inability to speak, read, or understand English; Resides more than 50 miles outside of the Twin Cities, Minnesota metropolitan area; Investigator discretion for safety or adherence reasons.